Director, Portfolio Development Process & Standards Lead Maidenhead

CSL R&D Overview

CSL's R&D organization is accelerating innovation to deliver greater impact for patients. With a project‑led structure and a focus on collaboration, we’re building a future‑ready team that thrives in dynamic biotech ecosystems. Joining CSL now means being part of an agile team committed to developing therapies that make a meaningful difference worldwide.

Could you be our next Director, Portfolio Development Process & Standards Lead? This position is located in our King of Prussia, PA;
Waltham, MA; or Maidenhead, UK office. It is a hybrid role, three days onsite. You will report to the Head, Portfolio Development Excellence, Process & Compliance.

You will be responsible for establishing and maintaining a framework that allows the Global Portfolio Development group, in collaboration with multiple partner functions across the organization, to plan, evaluate, and report clinical trials and programs under the highest quality standards.

• Manages all Portfolio Development (CD/BM/CO) owned SOP updates in collaboration with critical partner SMEs where appropriate and ensures they are updated to reflect current processes and structure.
• Drives the development of a fit‑for‑purpose technical training curriculum across PD that supports achieving quality program goals and standards.
• Provides guidance on process/procedural expectations and stakeholder management.

• Tracks and manages all Portfolio Development‑sponsored process development / improvement initiatives, in collaboration with the appropriate delegates and surface to PD CoS.
• Identifies and drives cross‑functional initiatives to bring in technology, may sponsor or lead cross‑functional initiatives supporting design and execution excellence.
• Tracks and manages all procedural documents update requirements to ensure compliance across the department in collaboration with the Portfolio Development Leadership Team and appropriate delegates.
• Provides innovative solutions to increase the excellence of Portfolio Development; aims to reduce complexity, increase quality and speed, and reduce decision‑making churn.
• Represents Portfolio Development for applicable cross‑functional R&D initiatives and forums.
• Core reviewer on all Portfolio Development SOP updates to ensure changes work systematically across procedural documents.

• Bachelor’s degree or equivalent in life sciences, nursing, pharmacy, medical laboratory technology, or other health/medical related field preferred.
• Other degrees and certifications considered if commensurate with related clinical research experience (e.g., diploma or associate degree RN, certified medical technologist).
• 12+ years of experience in the biotechnology or pharmaceutical industry (or biomedical research organization).
• In‑depth knowledge of drug development and GCP environment.
• 5+ years of experience in managing projects in Clinical Research and Development; first‑hand experience in the execution of clinical trials is required.
• 3+ years of experience in managing process improvement initiatives, and influencing change in an organization.
• Proven experience in leading cross‑functional, multicultural and international product development teams.

The expected base salary range for this position at hiring is $250,000 - $280,000. Please note this salary range reflects the minimum and maximum base pay that CSL expects to pay for this position listed for Waltham, MA at the time of this posting. Individual base salary for a successful candidate is determined by qualifications, skill level, experience, competencies and other relevant factors.

In addition to base salary, total compensation for this role may also include incentive compensation and equity.

CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives.

Equal Opportunity Employer CSL is an Equal Opportunity Employer. If you are an individual with a disability and need a reasonable accommodation for any part of the application process, please visit